Epilepsy is a common chronic neurologic disorder that affects 1-3 % of the population. When it comes to childhood absence epilepsy (CAE), a paediatric formulation of an antiepileptic drug is long overdue.
A significant proportion of epilepsy syndromes have their onset in childhood and adolescence, and there is a great heterogeneity with respect to syndrome type, causes and prognoses. CAE manifests with frequent, unpredictable, unprovoked absence seizures that usually involve impairment of consciousness. Patients often have family history, and in some cases, the condition is transmitted by autosomal recessive inheritance. The symptoms and potential comorbidities of CAE could affect patient social behaviour, self-esteem and learning ability.
Further information: Childhood epilepsy treatment